Y Yang, Y Cao - Seminars in cancer biology, 2022 - Elsevier
Metastasis is the leading cause of cancer-associated mortality and the underlying mechanisms of cancer metastasis remain elusive. Both blood and lymphatic vasculatures …
K Khalaf, D Hana, JTT Chou, C Singh… - Frontiers in …, 2021 - frontiersin.org
The tumor microenvironment (TME) is a complex and ever-changing “rogue organ” composed of its own blood supply, lymphatic and nervous systems, stroma, immune cells …
T Seki, Y Yang, X Sun, S Lim, S Xie, Z Guo, W Xiong… - Nature, 2022 - nature.com
Glucose uptake is essential for cancer glycolysis and is involved in non-shivering thermogenesis of adipose tissues,,,,–. Most cancers use glycolysis to harness energy for …
P Jin, J Jiang, L Zhou, Z Huang, EC Nice… - Journal of Hematology & …, 2022 - Springer
Drug resistance represents a major obstacle in cancer management, and the mechanisms underlying stress adaptation of cancer cells in response to therapy-induced hostile …
E Yang, X Wang, Z Gong, M Yu, H Wu… - Signal transduction and …, 2020 - nature.com
Metabolic reprogramming is reported to be one of the hallmarks of cancer, which is an adaptive mechanism by which fast-growing cancer cells adapt to their increasing energy …
M Huang, Y Lin, C Wang, L Deng, M Chen… - Drug resistance …, 2022 - Elsevier
Angiogenesis is a hallmark of cancer and is required for tumor growth and progression. Antiangiogenic therapy has been revolutionarily developing and was approved for the …
Lipid metabolic reprogramming is an emerging hallmark of cancer. In order to sustain uncontrolled proliferation and survive in unfavorable environments that lack oxygen and …
A Mukherjee, AJ Bilecz, E Lengyel - Cancer and Metastasis Reviews, 2022 - Springer
Many epithelial tumors grow in the vicinity of or metastasize to adipose tissue. As tumors develop, crosstalk between adipose tissue and cancer cells leads to changes in adipocyte …
G Luis, A Godfroid, S Nishiumi, J Cimino, S Blacher… - Redox biology, 2021 - Elsevier
Problem Tumor recurrence is a major clinical issue that represents the principal cause of cancer-related deaths, with few targetable common pathways. Mechanisms by which …